Breztri is an inhaled triple-combination therapy approved for the treatment of chronic obstructive pulmonary disease
Ticagrelor tablets are indicated for to reduce the risk of cardiovascular death and myocardial infarction,
Bayer expects 2025 to be the most difficult year of its turnaround
Ami Organics’ Ankleshwar Unit II gets GMP compliant by PMDA Japan
Akums and TNAU will collaborate to strengthen research through shared expertise and innovative agricultural solutions, to foster innovation in formulation development
The partnership provides Sai Life Sciences with a greenhouse gas emissions reduction of up to 90% for its international logistics needs by using SAF
Carbamazepine Tablets USP, 200 mg have an estimated market size of US$ 32 million for twelve months ending December 2024 according to IQVIA
YESAFILI, a vascular endothelial growth factor (VEGF) inhibitor, is used to treat several different types of ophthalmology conditions
The product will be launched in Q1FY26
The supply of these goods is set to commence within the first quarter of FY26
Subscribe To Our Newsletter & Stay Updated
